High TIRADS may signal cancer despite benign cytology

• by Andrea Surnit

• October 30, 2026

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

• by Kathryn Wighton

• August 10, 2026

• 1 min

Rare GI disease leads to 20-plus units of transfused blood

A rare intestinal lymphangioma caused life-threatening bleeding without typical laboratory features of protein-losing enteropathy

• by Teraya Smith

• October 5, 2026

• 2 min

Mild metabolic profile may mask MASLD risk

Five reproducible MASLD subtypes showed distinct genetic profiles and patterns of metabolic comorbidity and disease progression.

• by Andrea Surnit

• September 10, 2026

• 4 min